Comparative Outcome Assessment of EGFR TKIs for the Treatment of Advanced Non-Small-Cell Lung Cancer: A Network Meta-Analysis

被引：0
作者：
De Mello, Ramon Andrade [1 ]
Aguiar, Pedro, Jr. [2 ]
Cabral, Paloma [3 ]
Chaves, Fablo [4 ]
Liu, Davi [2 ]
Soares, Joao Paulo [4 ]
Mountzios, Giannis [5 ]
Tadokoro, Hakaru [2 ]
Lopes, Gilberto De Lima [6 ]
机构：
[1] Univ Algarve, Biomed Sci & Med Oncol Div, Faro, Portugal
[2] Univ Fed Sao Paulo, Med Oncol, Sao Paulo, Brazil
[3] Univ Fed Ceara, Med, Fortaleza, Ceara, Brazil
[4] Inst Canc Ceara, Med Oncol, Fortaleza, Ceara, Brazil
[5] Univ Athens, Sch Med, Med Oncol, Athens, Greece
[6] Ctr Paulista Oncol E Hcor Onco, Oncoclin Brasil Grp, Sao Paulo, Brazil
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
gefitinib; Erolotinib; afatinib; Non-small-cell lung cancer;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.02b-081
引用
收藏
页码：S1239 / S1240
页数：3
相关论文
共 50 条
[31]   EGFR-targeted therapies combined with chemotherapy for treating advanced non-small-cell lung cancer: a meta-analysis [J].
Peng Chen ;
Long Wang ;
Bing Liu ;
Hai-Zhong Zhang ;
Hong-Chen Liu ;
Zui Zou .
European Journal of Clinical Pharmacology, 2011, 67 :235-243
[32]   Efficacy and Safety of Vandetanib, a Dual VEGFR and EGFR Inhibitor, in Advanced Non-Small-Cell Lung Cancer: a Systematic Review and Meta-Analysis [J].
Zhang, Xinji ;
Qin, Yingyi ;
Li, Hui ;
Bai, Chong ;
Zhu, Tianyi ;
Xu, Jinfang ;
Wu, Cheng ;
Wu, Mengjie ;
Wang, Chaoxiang ;
Song, Hualing ;
Wei, Lixin ;
He, Jia .
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2011, 12 (11) :2857-2863
[33]   Meta-Analysis of First-Line Therapies in Advanced Non-Small-Cell Lung Cancer Harboring EGFR-Activating Mutations [J].
Haaland, Benjamin ;
Tan, Pui San ;
de Castro, Gilberto, Jr. ;
Lopes, Gilberto .
JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (06) :805-811
[34]   Toxicity comparisons of eight chemotherapy regimens in the treatment of metastatic/advanced non-small-cell lung cancer: a network meta-analysis [J].
Cheng, Ziming ;
Hou, Shizhen ;
Sun, Yi ;
Wu, Yubing ;
Liu, Bing ;
Yuan, Maoxi ;
Wang, Xiangdong .
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (06) :8709-+
[35]   MET inhibitors in advanced non-small-cell lung cancer: a meta-analysis and review [J].
Kim, Jung Han ;
Kim, Hyeong Su ;
Kim, Bum Jun .
ONCOTARGET, 2017, 8 (43) :75500-75508
[36]   A meta-analysis of adjuvant EGFR-TKIs for patients with resected non-small cell lung cancer [J].
Cheng, Hua ;
Li, Xiao-Jian ;
Wang, Xiao-Jin ;
Chen, Zuo-Wen ;
Wang, Rui-Qi ;
Zhong, Hong-Cheng ;
Wu, Tian-Chi ;
Cao, Qing-Dong .
LUNG CANCER, 2019, 137 :7-13
[37]   Efficacy and safety of first-line therapies in EGFR-mutated advanced non-small-cell lung cancer: a network meta-analysis [J].
Haeussler, Katrin ;
Wang, Xuan ;
Winfree, Katherine B. ;
D'yachkova, Yulia ;
Traore, Sory ;
Puri, Tarun ;
Thom, Howard ;
Papagiannopoulos, Christos ;
Nassim, Maria ;
Taipale, Kaisa .
FUTURE ONCOLOGY, 2022, 18 (16) :2007-2028
[38]   Should KRAS mutation still be used as a routine predictor of response to EGFR-TKIs in advanced non-small-cell lung cancer? A revaluation based on meta-analysis [J].
Min Ying ;
Xiaoxia Zhu ;
Kexu Chen ;
Zhou Sha ;
Longhua Chen .
Journal of Cancer Research and Clinical Oncology, 2015, 141 :1427-1439
[39]   Clinical efficacy of first-generation EGFR-TKIs in patients with advanced non-small-cell lung cancer harboring EGFR exon 20 mutations [J].
Chen, Dan ;
Song, Zhengbo ;
Cheng, Guoping .
ONCOTARGETS AND THERAPY, 2016, 9 :4181-4186
[40]   Can EGFR mutations in plasma or serum be predictive markers of non-small-cell lung cancer? A meta-analysis [J].
Wu, Ying ;
Liu, Hongbing ;
Shi, Xuefei ;
Song, Yong .
LUNG CANCER, 2015, 88 (03) :246-253
12345